Tuberculosis-related deaths within a well-functioning DOTS control program

Emerging Infectious Diseases

Volumn 8, Issue 11, 2002, Pages 1327-1333

  De Lourdes García García, Maria ^a   Ponce de León, Alfredo ^b   García Sancho, Maria Cecilia ^c   Ferreyra Reyes, Leticia ^a   Palacios Martínez, Manuel ^a   Fuentes, Javier ^d   Kato Maeda, Midori ^b   Bobadilla, Miriam ^b   Small, Peter ^e   Sifuentes Osornio, José ^b  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d SECRETARÍA DE SALUD   (Mexico)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ACID FAST BACTERIUM; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DEATH; DIRECTLY OBSERVED THERAPY; FEMALE; FOLLOW UP; GENOTYPE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUTUM ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0036850184     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0811.020021     Document Type: Article

References (41)

1. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: Burden, intervention and cost. Bulletin of the International Union Against Tuberculosis and Lung Disease 1990;65:6-24.
2. Visschedijk J, Simeant S. Targets for health for all in the 21st century. World Health Stat Q 1998;51:56-67.
3. Floyd K, Wilkinson D, Gilks C. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: Experience from rural South Africa. BMJ 1997;315:1407-11.
4. Migliori GB, Ambrosetti M, Besozzi G, Farris B, Nutini S, Saini, et al. Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group. Bull World Health Organ 1999;77:467-76.
5. García-García ML, Small PM, Garcia-Sancho C, Mayar ME, Ferreyra RL, Palacios M, et.al. Tuberculosis epidemiology and control in Veracruz, Mexico. Int J Epidemiol 1999;28:135-40.
6. García-García ML, Ponce de Leon A, Jimenez Corona MA, Jimenez Corona AJ, Palacios Martinez M, Balandrano Campos S, et al. Clinical consequences and transmissibility of drug resistant tuberculosis in Southern Mexico. Arch Intern Med 2000;160:630-6.
7. Koster FT, Curling GC, Aziz KM, Haque A. Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bull World Health Organ 1981;59:90:1-8.
8. Aaby P, Andersen M, Knudsen K. Excess mortality after early exposure to measles. Int J Epidemiol 1993;22:156-62.
9. García-García ML, Palacios Martinez M, Ponce de Leon A, Jimenez Corona ME, Jimenez Corona A, Balandrano-Campos S, et al. The role of core groups in transmitting tuberculosis in a high prevalence community in Southern Mexico. Int J Tuberc Lung Dis 2000;4:12-7.
10. Instituto Nacional de Estadistica, Geografia e informática. Estados Unidos Mexicanos. XII Censo General de Población y Vivienda 2000. Resultados Preliminares. Aguascalientes; Ags; Instituto Nacional de Estadística, Geografia e Informática; 2000. p. 10.
11. Dirección General de Epidemiología. Sistema único de información. Secretaría de Salud 2001;18:4-7.
12. Secretaría de Salud. Norma Oficial Mexicana NOM-006-SSA2 1993, para la prevención y control de la tuberculosis en la atención primaria a la salud. Diario Oficial de la Federación, 1995;26 de enero:20-29.
13. Modificación a la Norma Oficial Mexicana NOM-006-SSA2-1993. Para la prevención y control de la tuberculosis en la atención primaria a la salud. Diario Oficial de la Federación, 2000;octubre 31.
14. Nolte FS, Mechock B. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology, 6th Ed. Washington: ASM Press; 1995. p. 400-37.
15. Instituto Nacional de Diagnóstico y Referencia Epidemiológicas. Manual de Técnicas y Procedimientos de Laboratorio en Tuberculosis, México: Secretaría de Salud, 1992. p. 9-20.
16. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9.
17. Woelffer GB, Bradford WZ, Paz A, Small PM. A computer-assisted molecular epidemiologic approach to confronting the reemergence of tuberculosis. Am J Med Sci 1996;311:17-22.
18. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997;35:907-14.
19. Van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995;33:3234-8.
20. Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med 1999;130:971-8.
21. Hennekens CH, Buring J. Epidemiology in medicine. Boston: Little, Brown and Company; 1986. p. 87-90.
22. Computing Resource Center. Stata Reference Manual: Release 3. 5th Ed. Santa Monica (CA): The Center; 1992.
23. World Health Organization. Global Tuberculosis Control (WHO/CDS/TB/2001.287). Geneva, Switzerland: The Organization; 2001.
24. Connolly C, Davies GR, Wilkinson D. Impact of the human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991-1998. Int J Tuberc Lung Dis 1998;2:919-25.
25. Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan PJ, McAdam KP. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia. Int J Tuberc Lung Dis 1998;2:712-8.
26. Olle-Goig JE. Patients with tuberculosis in Bolivia: Why do they die? Rev Panam Salud Publica 2000;8:151-5.
27. Harries AD, Nyirenda TE, Banerjee A, Boeree MJ, Salaniponi FM. Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Trans R Soc Trop Med Hyg 1999;93:443-6.
28. Datta M, Radhamani MP, Selvaraj R, Paramasivan CN, Gopalan BN, Sudeendra CR, et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuber Lung Dis 1993;74:180-6.
29. Grzybowski S, Enarson D. [Results in pulmonary tuberculosis patients under various treatment program conditions]. Bulletin of the International Union Against Tuberculosis. 1978;53:70-5.
30. Mexican Ministry of Health. Vital Statistics. [cited 2001 July 4] Available from: URL: http://www.ssa.gob.mx/unidades/dgied/sns/vitales/cuadro3.htm
31. Bustamante-Montes LP, Escobar-Mesa A, Borja-Aburto VH, Gomez-Muñoz A, Becerra-Posada F. Predictors of death from pulmonary tuberculosis: The case of Veracruz, Mexico. Int J Tuberc Lung Dis 2000;4:208-15.
32. Lawn SD, Acheampong JW. Pulmonary tuberculosis in adults: Factors associated with mortality at a Ghanaian teaching hospital. West Afr J Med 1999;18:270-4.
33. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997;111:1168-73.
34. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: Treatment outcomes in 6 countries. JAMA 2000;283:2537-45.
35. Espinal MA, Dye C, Raviglione M, Kochi A. Rational 'DOTS plus' for the control of MDR-TB. lnt J Tuberc Lung Dis 1999;3:561-3.
36. Connolly C, Reid A, Davies G, Sturm W, McAdam KP, Wilkinson D. Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa. AIDS 1999;13:1543-7.
37. Perriens JH, St. Louis ME, Mukadi YB, Brown C, Prignot J, Pouthier F, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995;332:779-84.
38. Lucas SB, Hounnou A, Peacock C, Beaumel D, Djomand G, N'gbichi JM, et al. The mortality and pathology of HIV infection in a West African city. AIDS 1993;7:1569-79.
39. Glynn JR, Vynnycky E, Fine PE. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1999;149:366-71.
40. Heldal E, Naalsund A, Kongerud J, Tverdal A, Boe J. Deaths from active tuberculosis: Can we rely on notification and mortality figures? Tuber Lung Dis 1996;77:215-21.
41. Kahn K, Tollman SM, Garenne M, Gear JS. Who dies from what? Determining cause of death in South Africa's rural north-east. Trop Med Int Health 1999;4:433-41.